China To Invest $1 Billion To Ramp Up New Drug Innovation
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China will invest RMB 6.6 billion ($960 million) to launch a massive new drug development and manufacturing program from 2008 to 2010. Roughly 3,290 projects focused on preclinical studies and identifying new candidates are awaiting approval to initiate in 2009
You may also be interested in...
BIO Reaches Out To China, Encourages Harmonization
WASHINGTON - Chinese officials are in the process of building the country's biotech regulatory framework, and foreign and domestic companies see opportunities to help shape the country's path toward becoming a major biotech market
BIO Reaches Out To China, Encourages Harmonization
WASHINGTON - Chinese officials are in the process of building the country's biotech regulatory framework, and foreign and domestic companies see opportunities to help shape the country's path toward becoming a major biotech market
China’s Strongest Pharmas Likely To Thrive Through Innovation And Acquisition Despite Global Crisis
Analysts predict the country’s top 100 pharmas will collectively post a rise in operating profit of more than 20 percent in 2009.